These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2968780

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Hormone dependency and progestogen therapy in the treatment of endometrial cancer].
    Okada H, Nakata Y, Fujimoto J, Fujita H.
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2837-44. PubMed ID: 2959204
    [Abstract] [Full Text] [Related]

  • 4. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
    Hyder SM, Murthy L, Stancel GM.
    Cancer Res; 1998 Feb 01; 58(3):392-5. PubMed ID: 9458078
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA, Oza BP, Colomer R, Lupu R.
    Int J Oncol; 2005 Jun 01; 26(6):1507-15. PubMed ID: 15870863
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hormone dependence of malignant ovarian tumors--an in vitro model].
    Schieder K, Bieglmayer C, Kölbl H.
    Geburtshilfe Frauenheilkd; 1989 May 01; 49(5):437-41. PubMed ID: 2544477
    [Abstract] [Full Text] [Related]

  • 15. Modulation of aromatase activity in human endometrial stromal cells by steroids, tamoxifen and RU 486.
    Tseng L, Mazella J, Sun B.
    Endocrinology; 1986 Apr 01; 118(4):1312-8. PubMed ID: 2936597
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Mechanisms of the antitumor action of gestagens on endometrial cancer].
    Nishida M, Kasahara K, Tsuji T, Kaneko M, Iwasaki H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec 01; 38(12):2214-22. PubMed ID: 3805831
    [Abstract] [Full Text] [Related]

  • 18. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T, Kolodziejczyk J, Krzysiek J, Basta A, Sztefko K, Kurek S, Stachura J, Gregoraszczuk EL.
    Gynecol Endocrinol; 2002 Aug 01; 16(4):319-29. PubMed ID: 12396561
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
    Bakker GH, Setyono-Han B, Henkelman MS, de Jong FH, Lamberts SW, van der Schoot P, Klijn JG.
    Cancer Treat Rep; 1987 Nov 01; 71(11):1021-7. PubMed ID: 3119199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.